150 related articles for article (PubMed ID: 18844789)
1. C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome.
Halstead SK; Humphreys PD; Zitman FM; Hamer J; Plomp JJ; Willison HJ
J Peripher Nerv Syst; 2008 Sep; 13(3):228-35. PubMed ID: 18844789
[TBL] [Abstract][Full Text] [Related]
2. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
Halstead SK; Zitman FM; Humphreys PD; Greenshields K; Verschuuren JJ; Jacobs BC; Rother RP; Plomp JJ; Willison HJ
Brain; 2008 May; 131(Pt 5):1197-208. PubMed ID: 18184663
[TBL] [Abstract][Full Text] [Related]
3. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.
Halstead SK; Morrison I; O'Hanlon GM; Humphreys PD; Goodfellow JA; Plomp JJ; Willison HJ
Glia; 2005 Nov; 52(3):177-89. PubMed ID: 15968629
[TBL] [Abstract][Full Text] [Related]
4. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.
Halstead SK; O'Hanlon GM; Humphreys PD; Morrison DB; Morgan BP; Todd AJ; Plomp JJ; Willison HJ
Brain; 2004 Sep; 127(Pt 9):2109-23. PubMed ID: 15289269
[TBL] [Abstract][Full Text] [Related]
5. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.
Halstead SK; Humphreys PD; Goodfellow JA; Wagner ER; Smith RA; Willison HJ
Ann Neurol; 2005 Aug; 58(2):203-10. PubMed ID: 16049921
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
[TBL] [Abstract][Full Text] [Related]
7. Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse.
Bullens RW; Halstead SK; O'Hanlon GM; Veitch J; Molenaar PC; Willison HJ; Plomp JJ
Muscle Nerve; 2005 Jun; 31(6):751-60. PubMed ID: 15793847
[TBL] [Abstract][Full Text] [Related]
8. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
9. Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: an in and ex vivo imaging study in the mouse.
Rupp A; Morrison I; Barrie JA; Halstead SK; Townson KH; Greenshields KN; Willison HJ
Exp Neurol; 2012 Feb; 233(2):836-48. PubMed ID: 22197826
[TBL] [Abstract][Full Text] [Related]
10. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
Willison HJ; Plomp JJ
Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
[TBL] [Abstract][Full Text] [Related]
11. Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury.
O'Hanlon GM; Humphreys PD; Goldman RS; Halstead SK; Bullens RW; Plomp JJ; Ushkaryov Y; Willison HJ
Brain; 2003 Nov; 126(Pt 11):2497-509. PubMed ID: 12937083
[TBL] [Abstract][Full Text] [Related]
12. C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy.
McGonigal R; Cunningham ME; Yao D; Barrie JA; Sankaranarayanan S; Fewou SN; Furukawa K; Yednock TA; Willison HJ
Acta Neuropathol Commun; 2016 Mar; 4():23. PubMed ID: 26936605
[TBL] [Abstract][Full Text] [Related]
13. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates.
Plomp JJ; Molenaar PC; O'Hanlon GM; Jacobs BC; Veitch J; Daha MR; van Doorn PA; van der Meché FG; Vincent A; Morgan BP; Willison HJ
Ann Neurol; 1999 Feb; 45(2):189-99. PubMed ID: 9989621
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological evidence by single fibre electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome.
Sartucci F; Cafforio G; Borghetti D; Domenici L; Orlandi G; Murri L
Neurol Sci; 2005 Jun; 26(2):125-8. PubMed ID: 15995829
[TBL] [Abstract][Full Text] [Related]
15. Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome.
Jacobs BC; Bullens RW; O'Hanlon GM; Ang CW; Willison HJ; Plomp JJ
Muscle Nerve; 2002 Apr; 25(4):549-58. PubMed ID: 11932973
[TBL] [Abstract][Full Text] [Related]
16. An animal model of Miller Fisher syndrome: Mitochondrial hydrogen peroxide is produced by the autoimmune attack of nerve terminals and activates Schwann cells.
Rodella U; Scorzeto M; Duregotti E; Negro S; Dickinson BC; Chang CJ; Yuki N; Rigoni M; Montecucco C
Neurobiol Dis; 2016 Dec; 96():95-104. PubMed ID: 27597525
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles.
Liu JX; Willison HJ; Pedrosa-Domellöf F
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3226-32. PubMed ID: 19255160
[TBL] [Abstract][Full Text] [Related]
18. Changes in the neuromuscular synapse induced by an antibody against gangliosides.
Santafé MM; Sabaté MM; Garcia N; Ortiz N; Lanuza MA; Tomas J
Ann Neurol; 2005 Mar; 57(3):396-407. PubMed ID: 15732093
[TBL] [Abstract][Full Text] [Related]
19. Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle.
Kuwabara S; Misawa S; Takahashi H; Sawai S; Kanai K; Nakata M; Mori M; Hattori T; Yuki N
J Neuroimmunol; 2007 Sep; 189(1-2):158-62. PubMed ID: 17673301
[TBL] [Abstract][Full Text] [Related]
20. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal.
O'Hanlon GM; Plomp JJ; Chakrabarti M; Morrison I; Wagner ER; Goodyear CS; Yin X; Trapp BD; Conner J; Molenaar PC; Stewart S; Rowan EG; Willison HJ
Brain; 2001 May; 124(Pt 5):893-906. PubMed ID: 11335692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
